Marius Radu

1425 SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN FOR CHRONIC HCV GENOTYPE-1 INFECTION IN TREATMENT-NAÏVE PATIENTS: RESULTS FROM QUEST-1, A PHASE III TRIAL

Ira M. Jacobson, G.J. Dore, Graham R. Foster et al. · Journal of Hepatology · 2013 · 90 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Calcium carbonate as silver carrier in composite materials obtained in green seaweed extract with topical applications

Cristian Matei, Daniela Berger, Anca Dumbravă et al. · Journal of Sol-Gel Science and Technology · 2019 · 68 citations

Natural Sciences, Materials Engineering, Materials Science +15

O4 PROLONGED THERAPY OF HEPATITIS DELTA FOR 96 WEEKS WITH PEGYLATED-INTERFERON-α-2a PLUS TENOFOVIR OR PLACEBO DOES NOT PREVENT HDVRNA RELAPSE AFTER TREATMENT: THE HIDIT-2 STUDY

H. Wedemeyer, S. Ernst, Florin Alexandru Căruntu et al. · Journal of Hepatology · 2014 · 54 citations

Pharmacy, Pharmacotherapy, Hepatitis Pharmacotherapy +10

Physico‐Chemical Characterisation of Lipids from <i>Mytilus galloprovincialis</i> (L.) and <i>Rapana venosa</i> and their Healing Properties on Skin Burns

Diana Badiu, Alina M. Balu, Lucica Barbeș et al. · Lipids · 2008 · 43 citations

Life Sciences, Animal Sciences, Biochemistry +17

Critical patient disease characteristics

Doina Iovănescu, Cătălin Apostolescu, Cleo Roşculeț et al. · BMC Infectious Diseases · 2013 · 31 citations · Full text

Veterinary Medicine, Infectious Diseases, Critical Care Medicine +12